Skip to main content

Table 2 Estimated IC50 doses of breast cell lines treated with chemotherapeutics

From: EGFR associated expression profiles vary with breast tumor subtype

Cell Line 5-Florouracil (uM) Doxorubicin (nM) Carboplatin (uM) Paclitaxel (nM)
ME16C 6.0 (0.29) 32.8 (1.89) 37.5 (0.63) 0.052 (0.004)
HME-CC 1.1 (0.07) 35.5 (3.26) 48.3 (1.41) 0.025 (0.003)
SUM102 16.8 (0.82) 5.1 (0.27) 11.7 (0.26) 0.00057 (0.00001)
SUM149 28.6 (1.33) 45.0 (3.06) 7.7 (0.24) 0.71 (0.006)
MCF-7 1.2 (0.15) 56.9 (4.26) 89.4 (3.79) 0.23 (0.02)
ZR-75-1 8.4 (1.06) 26.5 (1.39) 62.6 (1.98) 0.99 (3.34)
  1. Note that the standard errors are presented within ().